Freeline Therapeutics Holdings plc (FRLN) is a biotechnology company focused on the development and innovation in the field of gene therapy. The company specializes in treating rare genetic diseases through therapeutic genes and advanced treatment methods. Freeline Therapeutics aims to utilize cutting-edge technologies to create effective therapeutic solutions for patients with rare genetic disorders. Investors interested in innovations in biotechnology and gene therapy may find the shares of Freeline Therapeutics Holdings plc (FRLN) to be an interesting investment opportunity.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
